Tertiary lymphoid structures in HCC: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy
The TLS may be associated with significantly longer recurrence-free and overall survival. This association may reflect synergy between TLS and adjuvant PD-1 inhibitor therapy in activating antitumor immune responses within tumors.
Authors
- Li-Xin Pan (ORCID: https://orcid.org/0000-0002-3491-5095)
- Jia‐Yong Su (ORCID: https://orcid.org/0000-0002-0960-5394)
- Jian‐Hong Zhong (ORCID: https://orcid.org/0000-0002-1494-6396)
- Yan Jiang (ORCID: https://orcid.org/0000-0002-3524-2857)
- Rong‐Rui Huo (ORCID: https://orcid.org/0000-0002-3723-9619)
- Pingping Guo (ORCID: https://orcid.org/0000-0002-5091-9387)
- Cheng‐Piao Luo
- Wei Tian (ORCID: https://orcid.org/0000-0003-1595-5910)
- Zhenzhen Li (ORCID: https://orcid.org/0000-0002-7035-6657)
- Le Li (ORCID: https://orcid.org/0000-0003-3849-4854)
- Jianrong Li (ORCID: https://orcid.org/0000-0002-8232-9322)
- Liang Ma (ORCID: https://orcid.org/0000-0001-8106-373X)
- Zhu‐Jian Deng
- Yi-Li Ma
Institutions
- Guangxi Medical University (CN)
- Guangxi Center for Disease Prevention and Control (CN)
Publication Details
- Journal
- Hepatology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1097/hep.0000000000001433
- Citations
- 10
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 10.45